Update on the applications and limitations of alpha-fetoprotein for hepatocellular carcinoma.
Hanif H, Ali MJ, Susheela AT, Khan IW, Luna-Cuadros MA, Khan MM, Lau DT.
World J Gastroenterol. 2022 Jan 14;28(2):216-229. doi: 10.3748/wjg.v28.i2.216.
Outcomes of patients presenting with elevated tumor marker levels but negative gadoxetic acid-enhanced liver MRI after a complete response to hepatocellular carcinoma treatment.
Kim KE, Sinn DH, Choi MS, Kim H.
PLoS One. 2022 Jan 27;17(1):e0262750. doi: 10.1371/journal.pone.0262750. eCollection 2022.
Normalization of Elevated Tumor Marker CA27-29 After Bilateral Lung Transplantation in a Patient With Breast Cancer and Idiopathic Pulmonary Fibrosis.
Copur MS, Wurdeman JM, Nelson D, Ramaekers R, Gauchan D, Crockett D.
Oncol Res. 2018 Apr 10;26(3):515-518. doi: 10.3727/096504017X15128550060375. Epub 2017 Dec 11.
Elevated cerebrospinal fluid beta-2 microglobulin as a tumor marker in a patient with myeloma of the central nervous system.
Alsobhi EM, Hashim IA, Abdelaal MA, Aljifri AM, Alshamy AM.
Saudi Med J. 2007 Jan;28(1):128-30.
Elevated serum levels of tumor marker CA19-9 in acute cholangitis.
Albert MB, Steinberg WM, Henry JP.
Dig Dis Sci. 1988 Oct;33(10):1223-5. doi: 10.1007/BF01536670.
Association between precystectomy epithelial tumor marker response to neoadjuvant chemotherapy and oncological outcomes in urothelial bladder cancer.
Bazargani ST, Clifford TG, Djaladat H, Schuckman AK, Wayne K, Miranda G, Cai J, Sadeghi S, Dorff T, Quinn DI, Daneshmand S.
Urol Oncol. 2019 Jan;37(1):1-11. doi: 10.1016/j.urolonc.2018.09.008. Epub 2018 Nov 20.
Late relapsing germ cell tumors with elevated tumor markers.
Che Y, Lusch A, Winter C, Große Siemer R, Buddensieck C, Albers P, Hiester A.
World J Urol. 2022 Feb;40(2):363-371. doi: 10.1007/s00345-021-03833-z. Epub 2021 Sep 13.
Tumor markers.
Seleznick MJ.
Prim Care. 1992 Dec;19(4):715-26.
Preoperative tumor marker elevations in colorectal cancer patients with peritoneal metastases should be used to help select patients for cytoreductive surgery.
Ghabra S, Chang D, Sugarbaker PH.
Eur J Surg Oncol. 2025 Jun;51(6):109720. doi: 10.1016/j.ejso.2025.109720. Epub 2025 Feb 21.
Serum Tumor Markers and Outcomes in Patients With Appendiceal Adenocarcinoma.
Yousef A, Yousef M, Zeineddine MA, More A, Fanaeian M, Chowdhury S, Knafl M, Edelkamp P, Ito I, Gu Y, Pattalachinti V, Naini ZA, Zeineddine FA, Peterson J, Alfaro K, Foo WC, Jin J, Bhutiani N, Higbie V, Scally CP, Kee B, Kopetz S, Goldstein D, Strach M, Williamson A, Aziz O, Barriuso J, Uppal A, White MG, Helmink B, Fournier KF, Raghav KP, Taggart MW, Overman MJ, Shen JP.
JAMA Netw Open. 2024 Feb 5;7(2):e240260. doi: 10.1001/jamanetworkopen.2024.0260.
